Director, Compound Development Team Leader - Oncology
jj is hiring for Director, Compound Development Team Leader - Oncology in Leiden, South Holland, Netherlands. Executive level, €101k–€175k a year stated. First seen October 29, 2026; open as of November 12, 2026. Jobs taken straight from company career pages — no aggregator in between.
With Destava: How well do you fit? · Tailor my résumé · Write a cover letter
- Company
- jj
- Where
- Leiden, South Holland, Netherlands
- Level
- Executive
- Pay stated
- €101k–€175k a year
- First seen
- October 29, 2026
- Listed via
- Workday
What the posting says
Leiden, South Holland, Netherlands Job Description: Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results. Join us in developing treatments, finding cures, and pioneering the path from lab to life while…
Read more and apply on jj's site
More jobs like this
Senior Scientist, Imaging (12 Month Contract)
Save to applyBM - DTP(血液肿瘤) - 上海
Save to applyExecutive Director, Cancer Vaccine Neoantigen Engineering — Early Infectious Disease
Save to applySenior Group Director, Clinical Scientist - Immunology
Save to apply
See all 1,153 Medical Scientists, Except Epidemiologists jobs
A search agent finds the jobs this list misses: the ones that mean the same without the same words. Have Destava watch for director, compound development team leader - oncology jobs in Leiden, South Holland, Netherlands, new matches every morning on your own account.
This page includes information from the O*NET 31.0 Database by the U.S. Department of Labor, Employment and Training Administration (USDOL/ETA). Used under the CC BY 4.0 license. O*NET® is a trademark of USDOL/ETA.